European Archives - Page 26 of 1195 - European Medical Journal

Novel Modulation System Reduces Food Allergenicity Effectively

Traditionally, FA management has focused on avoidance or reducing allergenicity by altering the protein structure of allergens through heat, pressure or other treatments.

Liver Disease Risk Elevated in Type 2 Diabetes

In this study, MASLD was identified in 50% of the T2DM cohort using non-invasive methods, slightly lower than some global estimates.

EAN 2025 Interview: Irena Rektorová

The overarching theme was selected 2 years prior to the Congress, so I was not directly involved, as I was the chair of the Education…

Adenotonsillectomy Effective for Paediatric Sleep Apnoea

Adenotonsillectomy improves sleep apnoea in children, effective regardless of positional dependency, study finds.

AI Surpasses Dermatologists in Facial Lesion Detection

A recent study has demonstrated that deep learning models can enhance diagnostic accuracy in differentiating these pigmented lesions.

Award spotlights role of genomics in conservation

While genomics is best known for its role advancing precision medicine, MGI Tech has pioneered a new use case in enviromental sustainability.

Novel Tuberculosis Drug Candidates Emerge as Safer Alternatives to Linezolid

Delpazolid and sutezolid show strong efficacy and reduced toxicity in Phase 2 TB trials, offering safer alternatives to linezolid for drug-resistant TB treatment.

Social Factors Linked to Cancer Treatment Gaps for People with HIV

A new study has found that people living with HIV (PWH) in the United States are less likely to receive cancer treatment if they live in areas with lower income or educational attainment.

New AI Model Improves Sudden Cardiac Death Prediction

MAARS uniquely integrates electronic health records, imaging reports, and contrast-enhanced cardiac MRI using a transformer-based neural network.

Re-Irradiation Shows Promise in Local Prostate Relapse

Patients treated on the entire prostate or surgical bed had better DMFS compared to those treated only on the relapse site.